Fact CheckerSign in

NCT05657847Recruiting

Novel Complex Radiodiagnostics of Peripherial Arthropathies

Source: ClinicalTrials.gov · Last updated 20 Dec 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Chronic peripherial arthritides are common diseases with soaring public health consequences. Our goal is to assess the role of photon-counting detector computed tomography in the diagnostics of peripherial arthropathies.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
12 Dec 2022
Start date
7 Mar 2022
Primary completion date
1 Feb 2027
Lead sponsor
Semmelweis University
NCT number
NCT05657847

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 7 Mar 2022 to the primary completion date, 1 Feb 2027
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • age: \<18 years, \> 100 years

Other

  • pregnant
  • breastfeeding

Who the study is looking for

  • Rheumatoid arthritis (EULAR/ACR Criteria) / Psoriatic arthritis (CASPAR Criteria)/ Crystal arthropathies
  • signed informed consent

Age in the registry: 18 years to 100 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Buda Hospital of the Hospitaller Order of Saint John of God
Coordinator of this site? Confirm its status
BudapestHungaryRecruiting
Semmelweis University
Coordinator of this site? Confirm its status
BudapestHungaryRecruiting
National Institute of Rheumatology and Physiotherapy
Coordinator of this site? Confirm its status
BudapestHungaryRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.